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ABSTRACT 
 
Protonation constants for the biologically-important thioamino acids cysteine (CSH), 
penicillamine (PSH) and glutathione (GSH), and the formation constants of their complexes 
with Cu(I), have been measured at 25 C and an ionic strength of 1.00 mol dm3 (Na)Cl using 
glass electrode potentiometry. The first successful characterisation of binary Cu(I)CSH and 
Cu(I)GSH species over the whole pH range was achieved in this study by the addition of a 
second thioamino acid, which prevented the precipitation that normally occurs. Appropriate 
combinations of binary and ternary (mixed ligand) titration data were used to optimise the 
speciation models and formation constants for the binary species. The results obtained differ 
significantly from literature data with respect to the detection and quantification of protonated 
and polynuclear complexes. The present results are thought to be more reliable because of the 
exceptionally wide pH and concentration ranges employed, the excellent reproducibility of 
the data, the close agreement between the calculated and observed formation functions, and 
the low standard deviations and absence of numerical correlation in the constants. The 
present formation constants were incorporated into a large Cu speciation model which was 
used to predict, for the first time, metal-ligand equilibria in the biofluids of the human eye. 
This simulation provided an explanation for the precipitation of metallic copper in lens and 
cornea, which is known to occur as a consequence of Wilson’s disease. 
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INTRODUCTION 
 
The fundamental role of copper in human physiology, pathology and medicine has been 
stressed in numerous reviews.1–4 As a redox-active trace element, copper, usually as Cu(I) or 
Cu(II), acts as a catalytic and structural cofactor in the chemistry of a wide range of 
biomolecules.4 Although Cu(I) is unstable to disproportionation to Cu(II) and Cu(s) in simple 
aqueous solutions (without complexing agents), there is increasing evidence that it is the 
predominant oxidation state in many physiological settings. By way of example, Cu(I) has 
been identified in transport proteins and is known to play an important role in copper 
homeostasis,5 the delivery of copper to mitochondria,6 tumour cell metastasis and cancer 
chemotherapy3. Furthermore, Cu(I) can act as a scavenger for superoxide radicals in tissues7 
and some complexes of Cu(I) are effective anti-inflammatory agents8. As a d10 ion, Cu(I) 
forms strong complexes with many organic ligands,9 at least in part because of its ‘back 
bonding’ capabilities. Being a ‘soft’ ion,10 Cu(I) has a particular tendency to bind to sulfur-
containing ligands. 
 
Due to this critical role of copper in biological systems, reliable knowledge of the interactions 
between Cu(I) and key ligands of biological relevance is important for understanding and 
modelling the behaviour of such systems. While there are many possible ligands that warrant 
study, the thioamino acids (Fig. 1): (R)-2-amino-3-sulfhydrylpropanoic acid (L-cysteine, HS-
CH2-CH(NH2)-COOH, ‘CSH’), (2S)-2-amino-3-methyl-3-sulfanylbutanoic acid (D-
penicillamine, HS-C(CH3)2-CH(NH2)-COOH, ‘PSH’); and -L-glutamyl-L-cysteinylglycine 
(glutathione, HOOC-CH(NH2)-(CH2)2-CO-NH-CH(CH2-SH)-CO-NH-CH2-COOH, ‘GSH’) 
are of particular significance. Cysteine, which occurs in blood plasma in the micromolar 
range,11 is one of the most important metal-binding agents in biological fluids12. Glutathione 
is a tri-peptide that also occurs in blood plasma13 at concentrations of several mol dm3 
(M, where M is introduced as an abbreviation for the concentration unit mol dm3) but at 
much higher levels (1 to 6 mM) in cells14. Glutathione is involved in the transport of Cu(I) 
among proteins and enzymes15,16 and in the way cells respond to heavy metal poisoning.17 
The drug penicillamine has been commonly employed as a treatment for Wilson’s disease18,19 
and has also been widely used to treat rheumatoid arthritis20. Interestingly, the naturally-
occurring thioamino acids cysteine and glutathione are conspicuously inactive as 
therapeutics.21 Given all of these aspects it is of interest to have a more detailed knowledge of 
the interactions of Cu(I) with these ligands. 
 
 
 
 
Fig. 1   Structural formulas of the thioamino acids CSH, PSH and GSH. 
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Unfortunately, quantification of Cu(I)thioamino acid systems is not easy. The major reasons 
for this are: (i) Cu(I) is readily oxidised or, as noted above, disproportionates to Cu(II) in 
aqueous media in the absence of suitable complexing agents;22 (ii) both the thioamino acids 
and their complexes are also readily oxidised; (iii) sparingly soluble precipitates are formed 
over wide pH ranges (especially with cysteine and glutathione); and (iv) all of these systems 
show pronounced tendencies to form protonated and polynuclear complexes.23 In spite of 
these difficulties the biological relevance of the Cu(I) complexes of these particular 
thioamino acids has motivated many attempts to characterize them. Unfortunately, however, 
there is little agreement about the stoichiometry of the species formed, let alone their 
formation constants (see, e.g., Refs. 24–26). In part this is because many of the previous 
studies were restricted to narrow ranges of conditions, mostly due to solubility limitations, 
with some measurements even being made at just a single pH.16,25,26 
 
The development by Hefter et al.27 of a reliable, generalized method for the quantitative study 
of Cu(I) complexes in aqueous solution, along with the availability of modern computational 
analysis, provides a basis for a thorough re-investigation of these systems. Accordingly, the 
present study reports the determination, by high-precision glass-electrode potentiometry, of 
the protonation constants of the thioamino acids CSH, PSH and GSH, and the formation 
constants of their complexes with Cu(I). Problems with precipitation were circumvented by 
the addition of a second thioamino acid, which produced solutions that remained 
homogeneous over the whole pH range.28 
 
The formation constants measured were incorporated into the JESS reaction database29 and 
used to calculate, for the first time, Cu speciation in the aqueous humour and lens fluid of the 
human eye. By taking into account the redox state of these fluids and tissues, the simulations 
provided an insight into the conditions for the precipitation of metallic copper which is 
known to be connected to the increased in vivo copper concentrations associated with 
Wilson’s disease. 
 
 
EXPERIMENTAL AND COMPUTATIONAL METHODS 
 
Materials. Analytical-grade reagents were used throughout. Concentrated volumetric 
standard solutions of HCl, NaOH, EDTA and CuCl2 (BDH, UK) were employed where 
appropriate. Thioamino acids (Sigma-Aldrich, USA,  99 %), solid CuCl (Sigma-Aldrich,  
99 %) and copper wire (99.99 %) were used as received. The ionic strength of all working 
solutions was kept constant at 1.00 M by the addition of NaCl (Ajax, Australia, 99.9 %). 
Concentrations of H+ and OH were cross-checked by acid-base titrations using Gran plots30. 
Alkali solutions were discarded after two weeks. All solutions were prepared using high 
purity water (Millipore Milli-Q system) that had been boiled and cooled under high purity ( 
0.1 ppm O2) Ar to minimise dissolved O2 and CO2. 
 
 
Apparatus. Measurements were made with a computer-controlled high precision titration 
system incorporating a high-impedance digital voltmeter, Metrohm model 655 burettes fitted 
with anti-diffusion valves, and jacketed tall-form glass vessels (150 cm3) capped with tight-
fitting machined PTFE tops. All measurements were made at 25.00  0.01 C. The galvanic 
cells used for the potentiometric titrations can be represented as: 
Page 4 of 22 
Ag|AgCl | 5 M NaCl  ||  5 M NaCl  ||  test solution, I = 1.00 M (Na)Cl  |  GE 
where GE is a glass electrode (Metrohm model 6.0101.000). Reference electrodes were either 
of commercial origin (Metrohm 6.0702.100) or ‘homemade’ using Ag wire in contact with 
solid AgCl and 5 M NaCl solution. Potentials were measured to 0.1 mV and stirring was 
provided by a PTFE-coated magnetic stirrer bar. Liquid junction potentials were assumed to 
be constant throughout. Glass electrodes were calibrated in terms of p[H] (= log10[H+]) 
using a single point in situ procedure.31,32 After calibration (dE/dt < 0.02 mV/min) in a 
solution containing (10 to 50) mM HCl, thioamino acid and (where appropriate) Cu(I) 
solutions were added and the mixtures titrated with 0.1000 M NaOH. The Nernstian 
performance of the electrodes over the entire p[H] range was checked regularly by titrations 
of strong acid (HCl) against strong base (NaOH) solutions at I = 1.00 M (Na)Cl. 
 
 
Copper(I) Generation. The general method developed previously27 for the 
determination of Cu(I) equilibria in aqueous solution was used. All operations were 
performed under high purity Ar. To minimise ingress of atmospheric gases, tubing was glass 
or copper, flexibly connected by the shortest possible lengths of PTFE bellows tubing. A 
stock solution of 50 mM CuCl in 0.1 M HCl at I = 1.00 M (Na)Cl was transferred to a 2 L 
round-bottomed flask containing a freshly cleaned (10 % HNO3) and dried Cu spiral and 
stirred for a few days under Ar. When required samples of this Cu(I) stock solution were 
withdrawn using a syringe burette. To ensure the integrity of the Cu(I) solution delivered to 
the titration cell, Cu spirals were also inserted into the connecting tubing and the burette 
cylinder. Three aliquots of the Cu(I) solution were withdrawn. The middle portion was used 
for titration while the first and last portions were analysed for [Cu(I)]T, where the subscript T 
indicates the total or analytical concentration, by aerial oxidation to Cu(II) followed by 
titration against standard EDTA using fast sulfon black indicator33. Concentrations of H+ 
were determined from Gran plots of titrations with NaOH solution30. Stock solution 
concentrations were determined to  0.1 % and were found to drift only very slowly (ca. 1 % 
per month). 
 
 
Titration Procedure. All solutions were maintained under high purity, pre-humidified 
Ar. Thioamino acid solutions were prepared immediately prior to titration with 
concentrations ranging from (5 to 21) mM for the protonation titrations. Metal + ligand 
titrations were performed with (4 to 10) mM total Cu(I) at metal/ligand ratios of 1:1, 2:3, 1:2, 
or 1:3 for the binary complexes and 1:1:1, 1:1:2, 1:1:3, 1:2:2 or 1:3:1 for the ternary (mixed 
ligand) systems; overall the ligand concentrations ranged between (4 to 25) mM. 
Precipitation, when present, typically occurred at 2.3  p[H]  6.9; under such circumstances, 
measurements commenced only after sufficient base had been added to dissolve any 
precipitates. 
 
 
Computational Analysis. Potentiometric titration data were processed using the ESTA 
suite of programs.34–36 Optimisations were carried out by a least squares minimisation of the 
objective function: 
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where N is the total number of experimental titration points, np is the total number of 
parameters to be optimised, ne is the total number of electrodes, obsnqY  and calcnqY  are the 
observed and calculated variable of the qth residual at the nth point respectively and Wnq is the 
corresponding weight at that point. Weights were calculated as: 
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where p is the optimisation parameter and p is the standard deviation of the titration 
parameters held constant during optimisation. Formation constants, electrode intercept E, 
vessel and burette concentrations were optimised in various combinations. Both weighted and 
unweighted objective functions were used and the sum of squares of residuals was minimised 
with respect to both total concentrations (OBJT) and electrode potentials (OBJE). Since 
OBJT is less sensitive to errors near end points, it is preferred to OBJE, which would require 
the use of non-unit weights that are difficult to determine.35 The electrode slope was assumed 
to be Nernstian (59.16 mV) throughout. 
 
The simulation program ESTA1, which allows for the calculation of electrode potentials from 
titre volumes, formation constant estimation, species distributions and so on, was used to 
analyse the data, particularly to assess the goodness-of-fit.34–36 A convenient graphical 
representation of the titration data is the proton formation function37, HZ , defined as: 
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where TL is the total ligand concentration, [OH] = Kw/[H+] and Kw is the ionic product of 
water under the titration conditions. The corresponding metal formation function37, MZ , is: 
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where TM is the total metal concentration and 
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For ternary systems, HZ  is defined with TL = TL1 + TL2 but MZ  is undefined. 
 
For the protonation constants, a Monte Carlo analysis was performed with 75 cycles to 
identify the parameters best refined simultaneously with the formation constants, the chosen 
set being the one that gave the smallest standard deviation in the parameters of interest. Full 
details of this procedure are given elsewhere.36 In contrast, metal-ligand formation constants 
were optimised without other parameters. Model selection was based on the magnitudes of 
the objective functions, the standard deviations of the constants, and graphical comparison of 
the observed and calculated HZ  and MZ  curves. Because of their more distinctive separation 
for titrations with different metal-to-ligand ratios, HZ  plots are shown for all systems. These 
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plots illustrate the reproducibility of the titrations and the good fit between the experimental 
and calculated data. For illustrative purposes, a plot of MZ  for the Cu(I)CSH system is 
shown in the ESI (Fig. S4). However, it should be noted: (i) MZ  curves for this system 
cannot be interpreted in a simple way and (ii) to distinguish clearly between multiple curves, 
fewer titrations have been plotted than in the HZ  plot (Fig. 4) for the same system. 
 
Overall formation constants, pqsr, corresponding to the equilibrium (ignoring charges): 
pM   +   qL   +  sL   +   rH   ⇌   MpLqLsHr 
with 
pqsr  =  [MpLqLsHr] / [M]p [L]q [L]s [H]r 
where M is Cu(I), L is the thioamino acid ligand, L is a second thioamino acid ligand (if 
present), and H is H+, were employed throughout. 
 
 
RESULTS AND DISCUSSION 
 
Protonation Constants 
 
General Comments. The experimental data used to determine the protonation constants 
of CSH, PSH and GSH are summarized in Table S1 in the Electronic Supplementary 
Information (ESI). The constants obtained are given in Table 1 together with their standard 
deviations calculated from the Monte Carlo analyses using an unweighted OBJT function. 
Note that such deviations were generated from the computational analysis; real errors can be 
up to an order of magnitude larger.38 The small objective functions are indicative of the 
reproducibility of the titration data and the goodness-of-fit of the models. The quality of the 
present results is further illustrated by the HZ  plot in Fig. 2, which includes all the data 
obtained from 18 titrations with solutions ranging from (5 to 21) mM GSH. The individual 
data sets and the model are virtually indistinguishable. The even more reproducible results 
obtained for the more stable CSH and PSH are shown in Figs. S1 and S2 in the ESI. 
 
 
Table 1   Measured protonation constants of the thioamino acids CSH, PSH and GSH at 25 
C in I = 1.00 M (Na)Cl. 
 
Systems OBJT lg011   lg012   lg013   lg014   
CSH 5.29E9 10.164  0.006 18.36  0.01 20.34  0.02  
PSH 4.88E9 10.470  0.006 18.46  0.01 20.48  0.01  
GSH 1.08E8 9.357  0.004 17.970  0.007 21.40  0.01 23.60  0.01 
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Fig. 2   Proton formation function for GSH at 25 C and I = 1.00 M (Na)Cl. Open symbols, 
experimental data; solid line, calculated curve. 
 
 
Cysteine. The present protonation constants for CSH are compared with literature values 
obtained at I = 1 M in various media in Table 2. Agreement amongst these studies is good, 
with the near-quantitative agreement between the present results and the only other study in 
NaCl media39 being particularly noteworthy. 
 
 
Table 2   Comparison of the present and literature protonation constants for CSH at 25 C and 
I = 1 M in various media. 
 
Medium lg011  lg012  lg013  Reference 
NaCl 10.164 18.36 20.34 This work 
NaCl 10.193 18.372 20.271 39 
NaClO4 10.19 18.44 20.53 40 
NaNO3 10.15 18.27 20.17 41 
     
 
 
Penicillamine. To the best of our knowledge, no protonation constants for PSH have been 
reported in the literature at I = 1 M in any medium. However the present results (Table 1) are 
in good agreement with the values lg011 = 10.50, lg012 = 18.42 and lg013 = 20.37 reported 
at 25 C and I = 0.5 M NaClO4 by Österberg et al.14 The reliability of the present constants is 
supported by the reproducibility of the data and the good fit between the observed and 
calculated HZ  curves (Fig. S2 in the ESI). Fig. 1 shows that PSH has similar structure to 
CSH but has two methyl groups on the -carbon atom adjacent to the thiol group. This 
decreases the acidity of PSH relative to CSH,42 consistent with their protonation constants 
(Table 1). 
 
 
Glutathione. Table 3 compares the present protonation constants for GSH with literature 
values obtained at I = 1 M in various media (there are a multitude of values reported for other 
conditions17). Although GSH is the most difficult of the present systems to quantify, being 
the most easily oxidized and having the most ionisable protons, the agreement among the 
various studies is very good, except for the early work of Stricks and Kolthoff.44 The 
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agreement between the present results and those of Crea et al.17 obtained under almost 
identical conditions in NaCl and in 1.0 M (KCl) is particularly gratifying. 
 
 
Table 3   Comparison of the present and literature protonation constants for GSH at 25 C 
and I = 1 M in various media. 
 
Medium lg011  lg012  lg013  lg014  Reference 
NaCl 9.357 17.970 21.40 23.60 Present work 
NaCla 9.302 17.884 21.375 23.616 17 
KCl 9.38 17.96 21.42 23.68 17 
KNO3 9.69 18.44 21.93 23.91 43 
KNO3 8.82 17.78   44 
 
a At I = 0.93 M (NaCl); similar values were also reported at I = 1.4 M (NaCl).17 
 
 
Cu(I)Thioamino Acid Systems 
 
General Comments. Before discussing the individual Cu(I)thioamino acid systems, a 
few general comments on their quantification are appropriate. The present experimental 
approach was designed to ensure that all dissolved copper was present as Cu(I), stabilized by 
excess Cl and/or any thioamino acids present. In addition, independently prepared Cu(I) 
stock solutions, freshly prepared ligand solutions of varying concentration, and differing 
Cu(I):ligand ratios were used throughout. The titration data obtained in this manner are 
summarised in Table S2 in the ESI. 
 
It is important to recognize that measurements on the binary Cu(I)CSH and Cu(I)GSH 
systems were severely restricted by precipitation over a wide range of p[H] (< 5.2 and 2.3 < 
p[H] < 6.9, respectively). Fortunately, it was found that the addition of a second thioamino 
acid suppressed the precipitation such that satisfactory data could be obtained over the whole 
p[H] range of interest.28 To the best of our knowledge this is the first time that this has been 
achieved: previous studies have mostly been measured over very restricted concentration 
ranges, sometimes at only one pH.25,26 The availability of reliable data for the ternary (mixed 
ligand) systems28 allowed the formation constants of the binary Cu(I)CSH and Cu(I)GSH 
systems to be refined in a manner that was impossible using the (truncated) binary data alone. 
 
Another significant problem in the quantification of Cu(I)thioamino acid systems is their 
tendency to form protonated and polynuclear complexes. This complicates model selection 
and makes imperative the availability of high quality data over wide concentration ranges of 
Cu(I), ligand and proton. The challenges in studying these systems are reflected in the lack of 
agreement among independent researchers, stretching over many decades, on the 
stoichiometry of the species formed, let alone the magnitudes of their corresponding 
formation constants. 
 
 
Cu(I)PSH Complexes. Among the three Cu(I)thioamino acid systems studied, 
Cu(I)PSH was the least complicated because there was no precipitation and titration data 
could be collected over a wide p[H] range (1.7  p[H]  11.5). The data obtained were best 
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modelled with the species Cu(PS), Cu(PS)H0, Cu2(PS)2H and Cu2(PS)H+ (Table 4). The 
reproducibility of the data and the agreement between the calculated and observed HZ  
curves are shown in Fig. S3 in the ESI. 
 
Also included in Table 4 are literature values of the formation constants for the Cu(I)PSH 
system obtained under conditions broadly similar to the present work. The presence of 
Cu(PS) has been claimed in several studies45,46 but there are large differences in the reported 
formation constants. The present result (lg110 = 12.42) is about the average of the earlier 
values, although it should be noted that the work of Vortisch et al.45 is not strictly comparable 
with the present study as their measurements were made in aqueous acetonitrile solutions. 
 
The species distribution for the Cu(I)PSH system is shown as a function of p[H] at two 
Cu(I):PSH ratios in Fig. 3. The most notable features of the distribution diagram were the 
dominance of dinuclear and/or protonated species (Cu2(PS)H+, Cu(PS)H0 and Cu2(PS)2H) 
regardless of the Cu(I):PSH ratio. The simplest mononuclear species, Cu(PS), only became 
dominant at p[H] > ca. 7.5. Significant amounts of free Cu(I) existed at p[H]  2 at all 
Cu(I):PSH ratios but became negligible at p[H] > 6 (Fig. 3). 
 
There is broad agreement amongst the various studies of the Cu(I)PSH system in that 
polynuclear complexes have been detected, although rather few have been quantified (Table 
4). Marked differences between the present and previous investigations exist with regard to 
the detection of protonated complexes. For example, Vortisch et al.45 reported Cu2(PS)0 
whereas the protonated form, Cu2(PS)H+, was detected in the present study. In a similar vein, 
Cu2(PS)34 was reported in several studies,25,45,46 while Cu2(PS)2H was identified in this 
work. The most likely explanation for these differences is that the present study covers a 
much wider p[H] range. For example, Mezyk and Armstrong25 reported Cu2(PS)34 and 
Cu(PS)23 from UV spectra recorded only at p[H] = 10.0; protonated species are negligible at 
this p[H] (Fig. 3). The species Cu(PS)23, claimed in Refs. 25 and 46, was not detected in Ref. 
45 or in the present study. Österberg et al.14 reported only Cu(PS)2H2 and Cu5(PS)43 but no 
evidence could be found in the present work for any of these species despite extensive 
modelling. 
 
 
Table 4   Present and literature values for the formation constants of Cu(I)PSH complexes. 
 
Methoda t/C Medium/M lg() Reference 
Poty 25 1 (NaCl) 110 12.42(6); 111 18.72(4); 
211 22.29(9); 221 34.44(10) 
Present workb 
Poty 25 0.5 (NaClO4) 122 39.18(3); 540 101.50(5) 14 
Spec 23 0.05c 120d; 230d,e 25 
Poty 20 0.1 (NaClO4)f 110 14.3; 210d; 230d 45 
Spec 20 1 (NaClO4) 110 10.52; 120d; 230d 46 
     
a Abbreviations: Poty – glass electrode potentiometry; Spec – UV-vis spectrophotometry. b 
OBJT = 1.02E8. c Measured at pH = 10.0 only. d Complex detected but no value given for 
the formation constant. e lgK = 113(14) was also reported for the equilibrium: 2 Cu(PS)23 ⇌ 
Cu2(PS)34 + (PS)2. f In 1 M CH3CN. 
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Fig. 3   Species distribution of Cu(I)PSH with [Cu]T = 5 mM at: (a) Cu:PSH = 1:1 and (b) 
Cu:PSH = 1:3. Dotted line: free Cu(I); dash-dot-dot: Cu2(PS)H+; dash-dash: Cu(PS)H0; dash-
dot: Cu2(PS)2H and solid curve: Cu(PS). 
 
 
Cu(I)CSH Complexes. The accessible p[H] region in the binary Cu(I)CSH system 
was restricted to p[H] > 5.2 due to precipitation (Fig. 4). Insufficient experimental 
information resulted in correlated formation constants which precluded determination of lg
110. Most studies of this system agree on the existence of Cu(CS) but the reported 110 values 
vary by almost eight orders of magnitude (Table 5). This sort of disagreement among 
independent studies usually indicates that the system is inherently complicated: either 
because of the number of overlapping species and/or the presence of specific experimental 
problems.36,37,47 Regardless, a value of 110 is required to achieve convergence and to fix the 
numerical values of the other formation constants, even though the value chosen has little 
effect on the stepwise formation constants of subsequent species. The value selected, lg110 = 
13.13, was determined polarographically at the same ionic strength and temperature in this 
laboratory48 and is the approximate average of the lg110 values reported by Vortisch et al.45 
and Bagiyan et al.46. 
 
Using this value along with the binary Cu(I)CSH data in the homogeneous region (5.2  
p[H]  11.4) yielded a model comprising Cu(CS), Cu2(CS)3H3, Cu2(CS)2H and Cu2(CS)0 
that accurately represented the experimental observations over this restricted p[H] range (Fig. 
4 and Fig. S4 in the ESI). The addition of PSH to the Cu(I)CSH system permitted data to be 
obtained without precipitation in the range 1.5  p[H]  11.9 (Fig. S5, Tables S3 and S4 in 
the ESI). The inclusion of Cu2(CS)H+ in the ternary model lowered OBJT by more than an 
order of magnitude. The species distribution for the ternary system at Cu(I):CSH:PSH = 1:1:3 
shows that the binary species Cu2(CS)H+ is predominant at p[H] < 2.5.28 The formation 
constants of the refined model for the Cu(I)CSH binary system are given in Table 5. The 
corresponding species distribution is shown in Fig. 5. Where comparisons are possible 
(Tables 4 and 5) the Cu(I)CSH complexes are ~3 orders of magnitude stronger than 
Cu(I)PSH, which is reflected in the absence of significant free Cu(I) concentrations over the 
entire p[H] range. Even at low p[H] the speciation is dominated by the dinuclear species 
Cu2(CS)H+ and Cu2(CS)0. At p[H] > ca. 6, Cu2(CS)3H3 becomes the predominant species 
especially, as would be expected, at higher Cu(I):CSH ratios. As for the Cu(I)PSH system 
(Fig. 3), the simplest mononuclear complex, Cu(CS), only becomes important at relatively 
high p[H] values (Fig. 5). 
Page 11 of 22 
 
Also listed in Table 5 are the formation constants reported for the Cu(I)CSH complexes in 
the literature under broadly comparable conditions to the present work. As for Cu(I)PSH, 
there is little agreement among these studies as to the stoichiometry of the species formed and 
again a number of species have been identified but not quantified. Also as for Cu(I)PSH, the 
major difference between the present results and previous investigations is the detection of 
protonated species. The tendency of CSH to form protonated and polynuclear complexes with 
a variety of metal ions is well known.23 Interestingly, Bagiyan et al.46 indicated that 
protonated complexes of Cu(CS) formed readily during their pH-metric titrations but only 
reported a value for 110 (Table 5). 
 
 
 
 
Fig. 4   Proton formation functions for Cu(I)CSH at 25 C and I = 1.00 M (Na)Cl with 
[Cu(I)]T = (4 to 5) mM. Open symbols, experimental data at Cu(I):CSH = 1:1, 2:3, 1:2 and 
1:3; solid lines, calculated curves. 
 
 
Table 5   Present and literature values for the formation constants of Cu(I)CSH complexes. 
 
Methoda t/C Medium/M lg() Reference 
Poty 25 1 (NaCl) 110 13.13c; 210 22.75(2); 211 25.36d; 
221 37.65(5); 233 59.69(5) 
This workb 
Poly 25 1 (NH4Cl) 110 19.19; 210e 24 
Spec 23 0.05f 120e; 230e,g 25 
Fluoro 25 Buffersh 111 23.0(1.4); 122 38.4(7.8) 26 
Poty 20 0.1 (NaClO4) 110 14.0; 210e; 230e 45 
Spec 20 1 (NaClO4) 110 11.38; 120e, 230e 46 
     
a Abbreviations: Poty – glass electrode potentiometry; Poly – polarography; Spec – UV-vis 
spectrophotometry; Fluoro – fluorometric titrations. b OBJT = 1.07E8. c Determined by 
polarography48. d Determined from the ternary Cu(I)CSHPSH potentiometric titrations28. 
 e Complex detected but no value given for the formation constant.  f Measured at pH = 10.0 
only. g lgK = 162(23) reported for the equilibrium: 2 Cu(CS)23 ⇌ Cu2(CS)34 + (CS)2. h 
Determined in buffer solutions at pH = 7.2, 8.1 and 9.0. 
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Fig. 5   Species distribution of Cu(I)CSH with [Cu]T = 5 mM at (a) Cu:CSH = 1:1 and (b) 
Cu:CSH = 1:3. Dash-dot-dot: Cu2(CS)H+; dash-dash: Cu2(CS)0; dotted line: Cu2(CS)3H3; 
dash-dot: Cu2(CS)2H and solid curve: Cu(CS). Since precipitation occurs in the binary 
system, curves are hypothetical at p[H] < 5.2. Consequently, the formation constant for 
Cu2(CS)H+ was determined from the ternary Cu(I)CSHPSH potentiometric titrations.28  
 
 
Consistent with the present findings, Harman and Sóvágó49 have pointed out that the degree 
of formation and stoichiometry of Mn+PSH polynuclear complexes should be markedly 
different from those for Mn+CSH due to steric inhibition by the -methyl substituents in the 
former. This insight contrasts markedly with earlier investigations25,45,46 that assumed the 
same model for Cu(I)CSH and Cu(I)PSH. 
 
 
Cu(I)GSH Complexes. Precipitation is more severe in the Cu(I)GSH binary system 
than in Cu(I)CSH, occurring over the range 2.3 < p[H] < 6.9 (Fig. S6 in the ESI). Using the 
binary system data, the ‘best’ model consisting of Cu(GS)2, Cu(GS)H, Cu(GS)H3+, 
Cu(GS)2H4, Cu(GS)2H23 converged, but with correlated formation constants. The addition 
of a second ligand, CSH, enabled data to be collected at 1.4  p[H]  11.6 (Fig. S7, Tables S3 
and S4 in the ESI) from which the formation constants for Cu(GS)H3+ and Cu(GS)H could 
be unambiguously evaluated. In the species distribution for the ternary system at 
Cu(I):CSH:GSH = 1:1:1, these binary species contribute up to 40 % of total Cu at p[H] of 1.5 
and 4.5 respectively.28 Furthermore, with the refined formation constants of these two 
species, a re-investigation of the binary model showed that the introduction of Cu2(GS)H0 
improved OBJT and the standard deviation of the binary species in the model. The formation 
constants for the binary complexes: Cu(GS)2, Cu(GS)H, Cu(GS)H3+, Cu(GS)2H4, 
Cu(GS)2H23 and Cu2(GS)H0 are listed in Table 6 and species distribution curves are shown 
in Fig. 6. 
 
While more species were detected in this system than for Cu(I)PSH and Cu(I)CSH 
(compare Tables 4, 5 & 6) the speciation is dominated at 3  p[H]  9 by a single species, 
Cu(GS)H–. The relative concentrations of the various species are more sensitive to the 
Cu(I):ligand ratio than the other systems (compare Figs. 3, 5 & 6). Another significant 
difference between Cu(I)GSH and the other two systems is that most of the detected species 
are mononuclear. On the other hand, as for the other systems, the simplest (110) species, 
Cu(GS)2–, is formed significantly only at high p[H]. The only polynuclear species observed in 
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this system is the neutral complex, Cu2(GS)H0, which predominates only over a narrow p[H] 
range (Fig. 6). 
 
Comparison of the present results with selected literature data (Table 6) again shows little 
agreement although, consistent with the present findings, both Cu(GS)2H23 and the dominant 
Cu(GS)H– were detected and quantified by other investigators.14,26 
 
 
Table 6   Present and literature values for the formation constants of Cu(I)GSH complexes 
at 25 C. 
 
Methoda Medium/M lg() Reference 
Poty 1 (NaCl) 110 11.05(3); 111 20.27c;113 26.04c; 
121 23.24(2); 122 32.63(3); 211 24.89(10) 
This workb 
Poty 0.5 (NaClO4) 111 24.9; 122 38.8(1) 14 
Fluoro Buffersd 111 22.3(6); 122 35.5(1.1) 26 
    
a Abbreviations: Poty – glass electrode potentiometry; Fluoro – fluorometric titrations. 
 b OBJT = 4.39E8. c Determined from the ternary Cu(I)CSHGSH potentiometric 
titrations28. d Determined in buffer solutions at pH = 7.2, 8.1 and 9.0. 
 
 
   
 
Fig. 6   Species distribution of Cu(I)GSH from the refined model with [Cu]T = 5 mM at (a) 
Cu:GSH = 1:1 and (b) Cu:GSH = 1:3. Long dash: Cu(GS)H3+; dash-dot-dot: Cu2(GS)H0; 
short dash: Cu(GS)H; dash-dot: Cu(GS)2H23; dotted line: Cu(GS)2H4 and solid curve: 
Cu(GS)2. Since precipitation occurs in the binary system, curves are hypothetical in the 
range 2.3 < p[H] < 6.9. Consequently, the formation constant for Cu(GS)H3+ and Cu(GS)H 
were refined from the ternary Cu(I)CSHGSH potentiometric titrations.28 
 
 
Of particular interest are studies that provide direct structural information for Cu(I)GSH 
species. Corazzo et al.15 have applied 1H-NMR, 13C-NMR and X-ray absorption spectroscopy 
to Cu(I)GSH solutions of varying pH and GSH:Cu(I). From 1H-NMR spectra of GSH as a 
function of pH, they derived microscopic protonation constants which show some parallels 
with the macroscopic constants obtained in this work (Table 3). Their 1H-NMR data for 
Cu(I)GSH solutions indicated deprotonation steps at pH  10, which are compatible with 
the deprotonation of the Cu(GS)H and Cu(GS)2H23 species around this pH observed in the 
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present work (Fig. 6). Also from 1H-NMR data, Corazzo et al.15 derived a GSH:Cu(I) ratio of 
ca. 1.2 in the Cu(I)GSH species present at pH = 7.2. This is again in accordance with Fig. 6 
which shows a mixture of predominantly Cu(GS)H and a small amount of Cu(GS)2H23 at 
this pH. However, these parallels might just be fortuitous given that Corazzo et al.15 used 
phosphate buffers in D2O (without applying corrections to pH meter readings), up to 10 times 
greater GSH and much lower Cl– concentrations than those employed in the present study. 
 
Both Corazzo et al.15 and Poger et al.16 performed X-ray absorption measurements (mostly at 
just one GSH concentration, one or two GSH:Cu(I) ratios, one pH and low or zero Cl– 
concentration) and concluded that Cu(I) is coordinated by 3 sulfur atoms. To account for 
measured GSH:Cu(I) ratios of 1.2 15 and 2.5 16 in the Cu(I)GSH complexes, they proposed 
polymeric15 and a dinuclear species, Cu2(GS)5,16 respectively. Such species were not detected 
in the present study, although GSH:Cu(I) ratios ranging from 1:1 to 3:1 were investigated. 
The Cu(I)GSH species containing fewer GSH ligands found in the present study appear 
plausible because Cu(I) is expected to be significantly coordinated to Cl– at 1 M NaCl. 
However, Corazzo et al.15 investigated solutions without and with Cl (albeit at much lower 
concentration resulting from CuCl(s) used for sample preparation) and concluded that Cl– can 
be discounted as a ligand for Cu(I). We therefore cannot explain the differences between our 
findings and those reported by them. However, under biological conditions when the total 
Cu(I) concentration is in the M range (see below) and the free Cu(I) is estimated to be very 
much less (say 1 pM) so that dimeric or polymeric Cu(I) species are most unlikely to 
predominate. 
 
Since GSH:Cu(I) ratios can change by several orders of magnitude in different biological 
contexts and almost no techniques are available to study metal-ligand binding directly at 
biological concentrations, neither the present potentiometric titrations nor the spectroscopic 
studies discussed above15,16 can unequivocally determine the ‘true’ Cu(I)GSH speciation 
under biological conditions. However, speciation modelling represents a viable way forward 
to extrapolate, in a thermodynamically rigorous way, to concentrations far below those which 
can be investigated experimentally.29 The physiological relevance of speciation models based 
on the present data is evidenced by the fact that they provide the first explanation of the 
formation of Kayser-Fleischer rings in the human eye from precipitation of metallic copper. 
 
 
Thermodynamic Modelling of Copper Speciation in the Human Eye 
 
The aqueous humour (‘AH’) of the human eye is enclosed in the small anterior (250 μL) and 
posterior (60 μL) chambers of the eye, the space between the lens and the cornea. It is a 
transparent, gelatinous fluid similar to blood plasma (‘BP’) but with a marked deficit of 
protein (0.02 % vs. 7 % in BP) and a 15 times higher concentration of ascorbate. The 
concentrations of trace metals like Cu and Fe, and of antioxidants such as ascorbate, 
glutathione and cysteine in the AH have been investigated extensively because they serve as 
markers for diseases and infections of the eye. Compared to healthy subjects, patients 
suffering from glaucoma, cataracts or diabetes generally have elevated copper concentrations 
in the lens and the vitreous and aqueous humours50. In Wilson’s disease (‘WD’), a rare 
genetic disorder that inhibits Cu excretion in the bile, Cu concentrations can become so high 
that metallic copper is precipitated in the cornea or the lens, giving rise to so-called ‘Kayser-
Fleischer rings’51 or ‘sunflower cataracts’52 respectively. These ocular manifestations of WD 
generally disappear following treatment with Cu-chelating agents, such as D-penicillamine. 
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The circulation of AH supplies nutrients and removes metabolites from the avascular cornea 
and lens. The oxygen concentration in the anterior AH, which is partly maintained by direct 
diffusion of O2(g) through the cornea, is higher than in arterial blood.53 Such O2 levels, in 
combination with UV radiation, require efficient mechanisms for the removal of highly 
reactive oxygen species (‘ROS’) that can cause tissue damage. Ascorbic acid and (reduced) 
thioamino acids are thus important low-molecular-weight antioxidants that keep the redox 
state of the AH at negative (reducing) values. 
 
In this work the Joint Expert Speciation System, JESS29, has been used to estimate the redox 
state and the speciation of copper in the AH of the human eye. Our previous simulations of 
copper speciation among low-molecular-weight ligands in blood plasma28,29 have established 
the prevalence of Cu(I) complexes with cysteine and glutathione. For the present calculations, 
six metals (including the redox-active trace metals Cu and Fe), some 40 ligands, a total of 
almost 5000 species and more than 5300 reactions were included in the model. Accurate 
formation constants for the Cu(I)thioamino acid complexes, obtained in the present work, 
underpinned these calculations. As for the BP models,28,29 the conditions for the present JESS 
simulations were chosen to be: a temperature of 25 °C and an ionic strength of 0.15 M, since 
most of the relevant complex formation constants have been reported for these conditions. 
While these conditions are not optimal, previous experience28,29 indicates that it is generally 
advisable to base modelling calculations on the best-characterised data and to adjust the 
parameters to match other conditions using appropriate thermodynamic relationships. In this 
study, the formation constants were determined in 1 M NaCl and were adjusted to the desired 
ionic strength of 0.15 M using a modified SIT equation.54 
 
 
Concentrations of redox-active ligands and redox state. The delicate interplay 
between various thiol/disulfide redox systems and ROSs in both redox signalling and 
oxidative stress has been reviewed recently.55 Owing to significant variations in the 
concentrations of reduced and oxidised species in the glutathione and cysteine pools of 
plasma, cytoplasm, nucleus and other organelles, the redox potentials as calculated by the 
Nernst equation for the various couples in these biofluids differ.55 For the redox systems 
relevant to this work (Table 7), all of which involve two-electron (non-radical) reactions, the 
Nernst equations are: 
E = E°′– (RT/2F) ln([RSH]2/[RSSR]) 
and 
E = E°′– (RT/2F) ln([AA]/[DHA]) 
where E°′/mV (pH = 7.4) has been reported as –264, –250 and +46 for GSSG/GSH, 
CSSC/CSH and DHA/AA respectively.56,64 To model such systems in a particular biofluid, it 
is necessary to estimate the concentrations of the reduced and oxidised species (Table 7). The 
widely different redox potentials of these couples suggest that they exist in a nonequilibrium 
steady state, although it is known that they are linked to each other by a continuous transfer 
of electrons.55,65 
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Table 7   Concentrations and redox potentials for various redox systems*. 
 
 Blood plasma Aqueous humour Lens water 
 [X]/(μM) E/mV [X]/(μM) [X]/(μM) 
GSH  2.80  0.91a 
3.39  1.04b 
2.08  0.15# c 
 
–137  9a 
1.9  0.3e 
5.5# f 
0.96  0.14# c 
3280  10g 
GSSG 0.14  0.04a 
0.27  0.17# c 
0.006  0.006e 
0.24  0.07# c 
95  25g 
CSH 9.7  3.2a –80  9a 14.3
# f 14.3i 
CSSC 40  7a 8g < 6g 
AA 53  12d +15 103 h 103 h 
DHA 5  2d 102 h 
 
 
* GSH, (reduced) glutathione; GSSG, oxidised glutathione (disulfide); CSH, cysteine; CSSC, 
cystine (disulfide); AA, ascorbic acid; DHA, dehydroascorbic acid. # Patients with cataract. 
a Ref. 56, b Ref. 57; c Ref. 58; d Ref. 59; e Ref. 60; f Ref. 61; g Ref. 62; h Ref. 63; i (estimated) 
 
 
Cytoplasm and blood plasma. Glutathione and ascorbic acid are considered the most 
active reducing substances in living tissues.65 Due to high intracellular GSH concentrations 
and low [GSSG]/[GHS] ratios, this couple buffers the redox state of cytoplasm with a redox 
potential of typically –240 to –220 mV.55,66 In contrast, the redox potentials of CSSC/CSH 
and DHA/AA are –140 mV67 and +80 mV65 respectively. 
 
In blood plasma, the redox potentials of GSSG/GSH and CSSC/CSH differ significantly, 
implying that the concentrations given in Table 7 refer to a steady state rather than to 
equilibrium. Plasma redox potentials generally become more oxidising with age but vary in 
individuals according to oxidative stress-related circumstances.67 Due to the high CSH 
concentrations, the CSSC/CSH pool constitutes the major low-molecular-weight 
thiol/disulfide redox couple in BP, playing a primary role in antioxidant defence and redox 
signalling between cells and tissues67 and acting as the predominant redox buffer in plasma.56 
Redox potentials close to the value for this couple have been adopted in our previous 
modelling of metal ion speciation in plasma (105 mV,28 –83 mV29). For the present 
simulation, an intermediate value of –89 mV was selected. 
 
The redox potential of the DHA/AA couple calculated from the concentrations given by Ref. 
59 is +15 mV, whereas other workers have reported that DHA is practically absent in the 
plasma and serum of normal human beings,68,69 implying a less positive or even negative 
redox potential for the DHA/AA couple. More recent studies have carefully assessed the 
analytical uncertainties in the determination of DHA and essentially confirmed the values 
given in Table 7.70,71 
 
 
Aqueous humour and lens. Since AH has a pH of 7.2, calculated E°′/mV values change 
slightly to –252, –238 and +52 for GSSG/GSH, CSSC/CSH and DHA/AA, respectively. 
Concentrations for GSH and GSSG in AH given by Riley et al.60 correspond to a redox 
potential of –153 mV, somewhat more negative than for BP. However, GSH concentrations 
appear to be uncertain as Pandya72 has reported a value of 32.4  0.9 μM, which is more than 
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15 times greater than that given by Riley et al.60 The concentrations in Table 7 correspond to 
a redox potential for the CSSC/CSH couple of –97 mV, slightly more negative than our 
selected value for BP. Given the likely redox buffering capacity of this couple, due to the 
high CSH concentration in AH, this value was selected for the present simulation. 
 
Concentrations of AA and DHA in AH have been given as 1 mM and 0.1 mM respectively,63 
corresponding to a redox potential of +21 mV. There is reasonable agreement about the AA 
concentration in AH, e.g. Pandya72 has reported a value of 1180  33 μM. However, as 
discussed above for BP, the concentration of 0.1 mM DHA (Table 7) is likely to be too high, 
implying that the actual redox potential for the DHA/AA couple is less positive than +21 mV. 
 
The GSG and GSSG concentrations reported by Dickinson et al.62 (Table 7) suggest a redox 
potential of –223 mV in “lens water” (the aqueous solution component of the lens, assumed 
to be 65 % of its total mass62). 
 
 
Prediction of Cu speciation and metallic Cu(s) precipitation. JESS is capable 
of calculating the speciation of Cu(II) and Cu(I) as a function of the prevailing redox 
potential, Eh. Metallic copper will become stable when Eh  E(Cu2+/Cu(s)), as calculated 
from the Nernst equation: 
E = E°(Cu2+/Cu(s)) + (RT/2F) ln[Cu2+] 
where [Cu2+] is the free Cu2+ concentration buffered by labile Cu binding to 
macromolecules73 such as albumin and other proteins (comprising > 95 % of total Cu).74 
Binding of Cu to small peptides and low-molecular-weight ligands like thioamino acids 
amounts to about 0.5 μM in BP, i.e. less than 5 %.74 Values in this range have been found for 
Cu in serum or plasma ultrafiltrate (eliminating ceruloplasmin, albumin and other proteins 
expected to bind Cu), but this < 30 kDa fraction was confusingly termed “free Cu”.75 The 
actual free (non-complexed) copper (oxidation state not specified) concentration in BP has 
been estimated to be in the picomolar (10−12 M) range.74 
 
The present BP simulation (Table 8) results in a Cu speciation close to those of our previous 
models.28,29 Free Cu+, and total Cu+ bound to the low-molecular-weight ligands included in 
the model, are in the concentration ranges given above. In accordance with our earlier 
simulations,28,29 Cu2+ complexes are present only in very small amounts. 
 
The protein content of AH is about 350 times lower than for BP; nevertheless, the fraction of 
Cu bound to low-molecular-weight ligands is expected to be similar. Assuming the same free 
Cu+ concentration for AH as for BP, the Cu speciation for AH is similar to that in BP but the 
total Cu+ concentration is slightly lower (Table 8). 
 
For ‘lens water’, a significantly lower free Cu2+ concentration of 10–19 M was selected to 
simulate the strong bonding to proteins and enzymes,76 which occur in the lens and cornea in 
high concentrations as part of the oxidative stress defence system. The results (Table 8) 
indicate a free Cu+ concentration lower than in AH but a higher total Cu+ concentration. This 
is a consequence of Cu mobilisation from proteins due to the high ligand (particularly GSH) 
concentrations (Table 7). It should be noted that due to Eh = 223 mV selected in the present 
model for ‘lens water’, the free Cu+ concentration (1.2  1013 M) is significantly higher than 
that of Cu2+ (1019 M, see above). In contrast, Rae et al.76 estimated much lower free Cu+ 
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concentrations for cytoplasm (< 1023 M vs. < 1018 M for Cu2+), which appears to be 
inconsistent with the strongly reducing conditions maintained in cells. 
 
As shown in Table 8, the present calculations reveal that all three biological fluids are 
normally under-saturated with respect to Cu(s) under non-pathological conditions, as 
indicated by the negative logarithmic ‘saturation indices’. 
 
In Wilson’s disease, however, the synthesis of ceruloplasmin and the excretion of Cu in bile 
are retarded by a mutation in Wilson ATPase located in hepatocytes. Assuming an increase in 
labile Cu by a factor of 6 (corresponding to an increase in lg(SI) by 0.78) that is typical for 
Wilson’s disease,75 results in Cu(s) supersaturation and possible deposition in the lens (and 
cornea, for which similar redox potentials and ligand concentrations are likely77) but not in 
blood plasma or aqueous humour. The formation of sunflower cataracts and Kayser-Fleischer 
rings is therefore directly explicable in terms of the metal-ligand equilibria concerned. 
 
Given the significantly negative redox potential (–240 mV) and high GSH content (ca. 5 
mM) of cytoplasm,66 the model further suggests that Cu(s) precipitation in hepatocytes is also 
likely when Cu excretion is retarded. 
 
The true value of these speciation calculations is that they reveal trends, rather than provide 
single answers, when different physiological contexts are compared. The species 
concentrations given in Table 8 should therefore not be taken as absolute values. Rather, they 
indicate how Cu(I) speciation, and associated properties like Cu(s) supersaturation, change in 
different biological fluids. Under the conditions simulated in this study, simple equilibrium 
considerations suggest the predominance of (i) mononuclear complexes since metal 
concentrations are low and of (ii) binary complexes since the concentrations of CSH and 
GSH are not simultaneously high; moreover, the only mononuclear species identified in the 
ternary system (Cu(CS)(GS)H40) is insignificant at physiological pH.28 These results are in 
accord with those obtained from the speciation calculations (Table 8). 
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Table 8   Copper speciation in various biofluids calculated from the present model at 25 C and I = 0.150 M 
 
 Biofluids 
 Blood plasma  Aqueous humour  Lens water 
 pH= 7.40  pH= 7.20  pH= 7.20 
 pe= 1.50  pe= 1.64  pe= 3.77 
 Eh = 89 mV  Eh = 97 mV  Eh = 223 mV 
Cu Species* [Cu]/M % Cutotal  [Cu]/M % Cutotal  [Cu]/M % Cutotal 
CuI(CS) 1.13  107 65  1.23  107 83  1.85  108 2 
CuI(GS)H 4.90  108 28  2.20  108 15  6.96  107 93 
CuIIGlnHis 4.46  109 3  1.27  109 < 1    
CuII(His)2 2.44  109 1  6.72  1010 < 1    
CuIIHisThr 1.75  109 1       
CuIIHisTyrH 9.36  1010 < 1       
CuI2(CS)    6.60  1010 < 1    
CuI(GS)2H23       2.50  108 3 
CuI(GS)2       5.51  109 < 1 
CuI2(CS)(GS)H2       1.43  1010 < 0.1 
Cu+ 6.68  1012 < 0.01  6.68  1012 < 0.01  1.21  1013 < 0.0001 
Cutotal# 1.74  107 100  1.47  107 100  7.45  107 100 
 
lg(SI) of Cu(s) 
 
1.00 
  
0.860 
  
0.471 
 
* Gln = glutaminate, His = histidinate, Thr = threoninate and Tyr = tyrosinate. # bound to low-molecular-weight ligands. 
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CONCLUSIONS 
 
The protonation constants of three thioamino acids (CSH, PSH and GSH) and the formation 
constants of their complexes with Cu(I) have been measured in aqueous solution by 
potentiometric titration using glass electrodes. The characterization of the Cu(I) complexes 
was particularly difficult because of precipitation of sparingly soluble solids over wide p[H] 
ranges and the large number of polynuclear and protonated species formed. Precipitation was 
prevented by the addition of a second thioamino acid, which enabled data to be collected over 
the whole p[H] range. Detailed numerical analysis yielded the formation constants for the 
binary systems (involving Cu(I) and only one ligand). 
 
The present results show some similarities to previous studies of these systems but also some 
significant differences. The most important of these concern the greater number of protonated 
and polynuclear complexes with different stoichiometries than those previously reported. 
This is almost certainly due to the much wider p[H] range investigated in this study. The 
present formation constants are considered to be more realistic for biological applications 
because they were obtained in a NaCl ionic medium as opposed to previous data measured in 
different background electrolytes. 
 
A thermodynamic speciation model employing the present constants confirms that Cu(I) is 
the predominant oxidation state of Cu in blood plasma, aqueous humour, cornea and lens of 
the human eye. Another important result is the predominance of mononuclear binary 
complexes of Cu(I) with thioamino acids, consistent with the low Cu(I) concentrations in 
these biological fluids. When the concentrations of low-molecular-weight Cu complexes are 
elevated, most commonly as a consequence of Wilson’s disease, the precipitation of metallic 
copper in the eye (as opposed to other tissues) can be reasonably attributed to the 
mobilisation of Cu into this compartment by the high concentrations of GSH and the 
corresponding negative redox potential. 
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